Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
(FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -44.01%397.42M | -47.98%393.71M | -45.07%442.63M | -45.80%495.72M | -26.96%709.81M | -20.12%756.84M | -17.10%805.85M | -7.65%914.56M | -6.17%971.8M | -2.91%947.49M |
Transactional financial assets | -10.46%53.42M | -18.75%60.58M | -18.75%60.58M | -19.98%59.66M | -19.98%59.66M | 0.00%74.56M | 1.36%74.56M | 8.63%74.56M | 8.63%74.56M | 8.63%74.56M |
Notes receivable and accounts receivable | 28.82%165.47M | 13.74%169.6M | 7.77%141.51M | 0.25%136.69M | -0.76%128.46M | 21.63%149.11M | -12.59%131.31M | -29.80%136.35M | -23.67%129.43M | -28.14%122.6M |
-Notes receivable | 267.96%507.79K | ---- | -90.86%196K | -85.57%334K | -93.51%138K | --2M | 68.21%2.14M | 44.03%2.31M | 22.61%2.13M | ---- |
-Accounts receivable | 28.56%164.96M | 15.29%169.6M | 9.40%141.31M | 1.73%136.36M | 0.79%128.32M | 20.00%147.11M | -13.28%129.17M | -30.41%134.04M | -24.15%127.31M | -27.52%122.6M |
Other receivables (including interest and dividends) | -24.29%11.07M | 38.16%20.11M | 25.27%20.38M | 36.94%18.57M | 17.79%14.63M | 0.47%14.56M | -16.60%16.27M | -27.04%13.56M | -21.90%12.42M | -65.51%14.49M |
-Other receivable | -24.29%11.07M | ---- | 25.27%20.38M | ---- | 17.79%14.63M | ---- | -16.60%16.27M | ---- | -21.90%12.42M | ---- |
Contractual assets | 294.23%4.42M | 76.85%1.06M | 76.85%1.06M | 86.36%1.12M | 82.37%1.12M | -30.05%601.38K | -30.05%601.38K | -30.45%601.38K | -30.47%614.54K | 546.44%859.77K |
Advance payment | -57.15%5.05M | -60.82%9.09M | -27.90%10.26M | -28.87%10.94M | -55.93%11.78M | -34.35%23.21M | -53.23%14.23M | -60.91%15.38M | -44.17%26.73M | -38.31%35.36M |
Inventories | 139.17%16.09M | 76.01%20.71M | 172.58%18.87M | 55.49%10.54M | 21.83%6.73M | -27.15%11.77M | -45.10%6.92M | -15.50%6.78M | -35.66%5.52M | 77.86%16.16M |
Other current assets | -14.11%2.8M | -25.29%2.9M | 6.50%5.3M | -46.39%3.46M | -55.88%3.26M | -34.72%3.89M | -37.16%4.98M | 43.49%6.45M | 44.43%7.39M | 96.49%5.95M |
Total current assets | -29.90%655.74M | -34.49%677.78M | -33.58%700.59M | -36.94%736.7M | -23.85%935.45M | -15.02%1.03B | -16.77%1.05B | -11.80%1.17B | -9.16%1.23B | -8.23%1.22B |
Non Current assets | ||||||||||
Other equity investment | 8.64%18.53M | -14.53%14.7M | -12.47%15.4M | 8.46%16.22M | 11.53%17.06M | 11.00%17.2M | 13.01%17.6M | -5.41%14.95M | -3.63%15.29M | 161.36%15.5M |
Long-term equity investment | 14.24%361.56M | 13.16%319.73M | 13.98%323.69M | 22.92%315.82M | 24.93%316.51M | 13.99%282.54M | 14.32%283.99M | 9.19%256.93M | 22.14%253.34M | 22.13%247.87M |
Fixed assets | 54.18%550.42M | ---- | 1,250.21%396.52M | ---- | 1,097.39%356.99M | ---- | -9.83%29.37M | ---- | -18.83%29.81M | ---- |
Fixed assets liquidation | ---- | ---- | --0 | ---- | ---- | ---- | --0 | ---- | --0 | ---- |
Constru in process | --0 | ---- | -66.93%135.49M | ---- | -61.17%152M | ---- | 33.90%409.74M | ---- | 47.67%391.43M | ---- |
Intangible assets | 15.36%193.31M | 8.69%187.62M | 3.25%183.08M | 19.23%177.73M | 9.84%167.57M | 10.61%172.62M | 11.14%177.32M | -8.57%149.07M | -8.39%152.56M | 28.85%156.05M |
Development expenditure | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 390.93%26.47M | --20.95M | -44.20%17.11M |
Long deferred expense | -73.11%757.84K | -57.22%1.43M | -24.54%1.6M | -8.55%2.32M | -7.42%2.82M | -6.01%3.34M | -56.00%2.12M | -60.93%2.53M | -62.92%3.04M | -64.04%3.55M |
Deferred tax assets | 20.96%54.98M | 39.76%50M | 49.41%47.95M | 67.96%48.32M | 73.01%45.46M | 23.59%35.77M | 12.32%32.09M | 1.99%28.77M | -6.03%26.27M | 30.04%28.95M |
Usufruct assets | -57.51%1.54M | 470.45%2.15M | 500.32%2.64M | 524.28%3.13M | 534.27%3.61M | -41.93%376.31K | -85.68%439.03K | -90.27%501.75K | -92.82%569.69K | --648.06K |
Other non current assets | -61.79%16M | -63.11%14.29M | -40.48%34.88M | -5.74%37.25M | 42.93%41.87M | 25.53%38.74M | 126.31%58.59M | 57.03%39.52M | 117.55%29.29M | 205.84%30.86M |
Total non current assets | 8.45%1.2B | 9.85%1.13B | 12.85%1.14B | 17.83%1.12B | 19.65%1.1B | 16.88%1.03B | 21.00%1.01B | 17.28%948.15M | 23.14%922.56M | 30.23%877.21M |
Total assets | -9.14%1.85B | -12.42%1.8B | -10.85%1.84B | -12.40%1.85B | -5.19%2.04B | -1.66%2.06B | -1.76%2.07B | -0.78%2.12B | 2.36%2.15B | 4.72%2.09B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Notes payable and accounts payable | 9.84%57.77M | -5.95%43.69M | -40.72%44.2M | -22.04%46.96M | -38.91%52.6M | -40.67%46.45M | -11.76%74.57M | -42.70%60.23M | -17.47%86.1M | -10.27%78.3M |
-Accounts payable | 9.84%57.77M | -5.95%43.69M | -40.72%44.2M | -22.04%46.96M | -38.91%52.6M | -40.67%46.45M | -11.76%74.57M | -42.70%60.23M | -17.47%86.1M | -10.27%78.3M |
Contract liabilities | 5.89%91.99M | -18.52%62.89M | -0.44%71.46M | -4.86%80.56M | 4.18%86.87M | 18.85%77.18M | 6.81%71.78M | -3.13%84.67M | -17.28%83.39M | -9.68%64.94M |
Advance receipts | --75.22K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Salaries payable | -28.64%23.43M | -11.90%18.24M | -1.30%18.17M | -5.94%18.51M | 8.17%32.84M | -35.23%20.7M | -25.86%18.41M | -10.59%19.68M | -17.80%30.36M | 10.16%31.97M |
Taxs payable | 11.38%7.85M | 164.67%6.79M | -12.88%4.27M | 10.01%4.14M | 33.91%7.04M | 24.41%2.57M | -14.90%4.9M | -68.77%3.77M | -67.73%5.26M | -76.88%2.06M |
Other payable (including interest and dividends) | 846.86%55.72M | 759.17%32.45M | 7.89%4.59M | 89.70%6.77M | 24.93%5.88M | -7.31%3.78M | -16.46%4.25M | -17.64%3.57M | 13.75%4.71M | -43.38%4.08M |
-Dividend payable | ---- | --10M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Other payable | 846.86%55.72M | ---- | 7.89%4.59M | ---- | 24.93%5.88M | ---- | -16.46%4.25M | ---- | 13.75%4.71M | ---- |
Non current liabilities due within one year | -98.40%1.38M | -97.58%2.03M | -97.14%2.41M | -98.03%1.66M | 2.32%86.1M | 29.23%84.19M | 28.67%84.18M | 27.29%84.23M | 20.76%84.15M | 551.50%65.15M |
Other current liabilities | 327.88%282.79K | --211.54K | 212.82%211.61K | -74.29%53.15K | -67.29%66.09K | ---- | -6.34%67.65K | 26.06%206.72K | 5.88%202.07K | -98.94%4.97K |
Total current liabilities | -12.12%238.51M | -29.19%166.31M | -43.71%145.31M | -38.11%158.64M | -7.74%271.41M | -4.72%234.87M | 2.08%258.15M | -13.76%256.34M | -11.49%294.17M | 14.78%246.5M |
Current liabilities | ||||||||||
Long term loan | ---- | ---- | ---- | ---- | -40.76%66.22M | -5.92%86.22M | -30.49%47.78M | 58.03%111.78M | 407.38%111.78M | 6.57%91.65M |
Estimate liabilities | 25.55%26.51M | --1.88M | --2.66M | --13.72M | --21.12M | ---- | ---- | ---- | --0 | ---- |
Deferred tax liabilities | -5.96%5.22M | -40.25%5.5M | -39.71%5.6M | -41.70%5.47M | -41.38%5.55M | -3.53%9.21M | -3.50%9.29M | 10.53%9.38M | 10.42%9.46M | --9.55M |
Long term deferred income | 0.00%2.34M | 37.65%2.34M | 37.65%2.34M | --2.34M | --2.34M | --1.7M | --1.7M | ---- | --0 | ---- |
Lease liabilities | -84.69%219.58K | --217.18K | --214.01K | --1.31M | --1.43M | ---- | ---- | ---- | --0 | ---- |
Total non current liabilities | -64.53%34.29M | -89.76%9.94M | -81.59%10.82M | -81.15%22.84M | -20.27%96.66M | -4.02%97.13M | -25.00%58.77M | 52.94%121.16M | 262.90%121.24M | 13.95%101.19M |
Total liabilities | -25.88%272.8M | -46.91%176.25M | -50.74%156.13M | -51.92%181.48M | -11.40%368.07M | -4.51%332M | -4.32%316.92M | 0.27%377.5M | 13.57%415.41M | 14.53%347.69M |
Shareholders equity | ||||||||||
Paid-in capital | -1.65%392.17M | -1.98%392.17M | -1.98%392.17M | -0.34%398.75M | -0.34%398.75M | 0.00%400.1M | 0.00%400.1M | 0.00%400.1M | 0.00%400.1M | 0.00%400.1M |
Capital reserve funds | -12.95%682.61M | -15.57%681.46M | -12.87%698.12M | -1.62%786.92M | -1.86%784.17M | -1.20%807.12M | -1.65%801.26M | -1.92%799.86M | -1.73%799.05M | 1.39%816.88M |
Surplus reserve funds | 0.00%65.98M | 0.00%65.98M | 0.00%65.98M | 0.00%65.98M | 0.00%65.98M | 1.75%65.98M | 1.75%65.98M | 1.75%65.98M | 1.75%65.98M | 10.16%64.84M |
Retained profit | -10.03%427.15M | -8.40%481.12M | -13.28%478.92M | -13.73%470.98M | -12.78%474.77M | -2.76%525.22M | -2.56%552.25M | -1.68%545.96M | 1.03%544.31M | 3.91%540.11M |
Less:Treasury stock | --0 | ---- | --0 | -18.92%100.01M | -19.62%100.01M | -1.19%123.35M | -1.19%123.35M | -4.17%123.35M | -3.33%124.42M | -3.01%124.83M |
Other composite income | 62.18%-990.78K | -103.00%-5.06M | -95.68%-4.18M | -89.66%-3.45M | -72.48%-2.62M | -86.17%-2.49M | -68.25%-2.14M | -71.83%-1.82M | -50.86%-1.52M | -40.43%-1.34M |
Shareholders equity without minority interests | -3.34%1.57B | -3.40%1.62B | -3.73%1.63B | -4.01%1.62B | -3.71%1.62B | -1.37%1.67B | -1.52%1.69B | -1.13%1.69B | -0.21%1.68B | 2.48%1.7B |
Minority interests | -73.85%13.13M | -77.97%12.18M | -0.43%54.71M | 2.04%53.23M | -3.66%50.21M | 7.97%55.3M | 7.00%54.94M | 3.30%52.16M | 7.23%52.12M | 22.15%51.22M |
Total shareholder equity | -5.46%1.58B | -5.79%1.63B | -3.62%1.69B | -3.82%1.67B | -3.71%1.67B | -1.09%1.73B | -1.28%1.75B | -1.00%1.74B | -0.00%1.74B | 2.97%1.75B |
Total liabilityies and equity | -9.14%1.85B | -12.42%1.8B | -10.85%1.84B | -12.40%1.85B | -5.19%2.04B | -1.66%2.06B | -1.76%2.07B | -0.78%2.12B | 2.36%2.15B | 4.72%2.09B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
Auditor | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Tianjian Certified Public Accountants (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.